Effect of sodium butyrate on human breast cancer cell lines.
We have investigated the effects exerted by sodium butyrate (NaBu) on the growth and cell cycle perturbations of four human breast cancer cell lines (MCF7, T47D, MDA-MB231 and BT20) with different steroid receptor profiles. Moreover, since one of the supposed mechanisms of action for NaBu activity involves the induction of apoptosis, we have studied the effects of NaBu on DNA fragmentation by agarose gel electrophoresis and flow cytometry. In all investigated cell lines, NaBu exerted a time- and dose-dependent inhibition of growth and caused a maximum inhibitory effect (85% to 90%) at the concentration of 2.5 mM. The inhibition was already evident after 3 days of treatment. The antiproliferative effect of NaBu was associated with a persistent block of cells in the G2M phase. The block was associated with apoptosis only in oestrogen-receptor positive cell lines. The inhibiting effect of NaBu in hormone-dependent and independent cell lines and its ability to induce apoptosis through a cell cycle perturbation in hormone-dependent cell lines may have important implications in the treatment of human tumours including breast cancer.
Coradini
D
D
Oncologia Sperimentale C. Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
Biffi
A
A
Costa
A
A
Pellizzaro
C
C
Pirronello
E
E
Di Fronzo
G
G
D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy*; D002087:Butyrates / Q000494:pharmacology*; D020148:Butyric Acid; D002453:Cell Cycle / Q000187:drug effects; D053938:DNA Fragmentation; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D011987:Receptors, Steroid / Q000032:analysis; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D002087:Butyrates; D011987:Receptors, Steroid; D020148:Butyric Acid